Expect Pfizer/BioNTech and Moderna Coronavirus Vaccine Data Readouts in November-December, U.S. Vaccine Program Head Says

Brian Orelli, PhD, The Motley Fool
·2-min read
Expect Pfizer/BioNTech and Moderna Coronavirus Vaccine Data Readouts in November-December, U.S. Vaccine Program Head Says
Expect Pfizer/BioNTech and Moderna Coronavirus Vaccine Data Readouts in November-December, U.S. Vaccine Program Head Says

The head of the U.S. government's Operation Warp Speed COVID-19 vaccine program, Moncef Slaoui, said he expects phase 3 clinical trial data for multiple coronavirus vaccines in the November-to-December timeframe. BNT162b2, the vaccine developed by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) and mRNA-1273 from Moderna (NASDAQ: MRNA) will be in the first round Slaoui said at a symposium conducted by the Johns Hopkins University and the University of Washington. Pfizer and BioNTech have said they could have data as early as the end of this month.